MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts

被引:32
|
作者
Fordham, Jezrom B. [1 ]
Guilfoyle, Katherine [2 ,3 ]
Naqvi, Afsar Raza [1 ]
Nares, Salvador [1 ]
机构
[1] Univ Illinois, Dept Periodont, Chicago, IL USA
[2] Univ N Carolina, Sch Dent, Dept Periodont, 385 S Columbia St, Chapel Hill, NC 27599 USA
[3] Sarasota Periodont, 450 Maple Ave, Sarasota Springs, NY 12866 USA
来源
SCIENTIFIC REPORTS | 2016年 / 6卷
基金
美国国家卫生研究院;
关键词
KINASE-C-ALPHA; MACROPHAGE; MIR-30B; MIR-24; RNAS;
D O I
10.1038/srep24980
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNA are small, non-coding, single-stranded RNAs that are estimated to regulate similar to 60% of the human genome. MiRNA profiling of monocyte-to-osteoclast differentiation identified miR-142-3p as a miRNA that is significantly, differentially expressed throughout osteoclastogenesis. Enforced expression of miR-142-3p via transient transfection with miR-142-3p mimic inhibited cell-to-cell contact and fusion, decreased protein kinase C alpha expression, and ultimately reduced cell viability. miR-142-3p was also identified as significantly differentially expressed during monocyte-to-macrophage differentiation and overexpression of miR-142-3p prevented their conversion to osteoclasts. Furthermore, the inhibitory effect of miR-142-3p on osteoclastogenesis extended to the conversion of a third osteoclast precursor cell type-dendritic cells. These results demonstrate miR-142-3p to be a negative regulator of osteoclastogenesis from the 3 main precursor cell types: monocytes, macrophages and dendritic cells. Importantly, decreased survival was dependent upon both miR-142-3p expression and RANK-signaling, with no harmful effects detected in the absence of this combination. As such, miR-142-3p represents a novel target for the selective removal of osteoclasts by targeting of osteoclastogenic pathways.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Low expression of miR-142-3p promotes intervertebral disk degeneration
    Xue, Jianmin
    Hu, Baoyang
    Xing, Wenhua
    Li, Feng
    Huang, Zhi
    Zheng, Wenkai
    Wang, Bo
    Zhu, Yong
    Yang, Xuejun
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2021, 16 (01)
  • [22] miR-142-3p inhibits cancer cell proliferation by targeting CDC25C
    Cao, Xu-Chen
    Yu, Yue
    Hou, Li-Kun
    Sun, Xiao-Hu
    Ge, Jie
    Zhang, Bin
    Wang, Xin
    CELL PROLIFERATION, 2016, 49 (01) : 58 - 68
  • [23] miR-142-3p as a biomarker of blastocyst implantation failure A pilot study
    Borges, Edson, Jr.
    Setti, Amanda Souza
    Braga, Daniela P. A. F.
    Geraldo, Murilo V.
    Figueira, Rita de Cassia S.
    Iaconelli, Assumpto, Jr.
    JORNAL BRASILEIRO DE REPRODUCAO ASSISTIDA, 2016, 20 (04): : 200 - 205
  • [24] Growth Inhibition of Retinoblastoma Cell Line by Exosome-Mediated Transfer of miR-142-3p
    Plousiou, Meropi
    De Vita, Alessandro
    Miserocchi, Giacomo
    Bandini, Erika
    Vannini, Ivan
    Melloni, Mattia
    Masalu, Nestory
    Fabbri, Francesco
    Serra, Patrizia
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2119 - 2131
  • [25] miR-142-3p Controls the Specification of Definitive Hemangioblasts during Ontogeny
    Nimmo, Rachael
    Ciau-Uitz, Aldo
    Ruiz-Herguido, Cristina
    Soneji, Shamit
    Bigas, Anna
    Patient, Roger
    Enver, Tariq
    DEVELOPMENTAL CELL, 2013, 26 (03) : 237 - 249
  • [26] miR-142-3p acts as an essential modulator of neutrophil development in zebrafish
    Fan, Hong-Bo
    Liu, Yi-Jie
    Wang, Lei
    Du, Ting-Ting
    Dong, Mei
    Gao, Li
    Meng, Zhao-Zheng
    Jin, Yi
    Chen, Yi
    Deng, Min
    Yang, Huang-Tian
    Jing, Qing
    Gu, Ai-Hua
    Liu, Ting-Xi
    Zhou, Yong
    BLOOD, 2014, 124 (08) : 1320 - 1330
  • [27] Intrinsic T-cell regulator miR-142-3p/5p – a novel therapeutic target?
    Sebastian Dolff
    Wayel H. Abdulahad
    Benjamin Wilde
    Cellular & Molecular Immunology, 2021, 18 : 508 - 509
  • [28] Intrinsic T-cell regulator miR-142-3p/5p-a novel therapeutic target?
    Dolff, Sebastian
    Abdulahad, Wayel H.
    Wilde, Benjamin
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (02) : 508 - 509
  • [29] Downregulation of Plasma MiR-142-3p and MiR-26a-5p in Patients With Colorectal Carcinoma
    Ghanbari, Reza
    Mosakhani, Neda
    Asadi, Jahanbakhsh
    Nouraee, Nazila
    Mowla, Seyed Javad
    Yazdani, Yaghoub
    Mohamadkhani, Ashraf
    Poustchi, Hossein
    Knuutila, Sakari
    Malekzadeh, Reza
    IRANIAN JOURNAL OF CANCER PREVENTION, 2015, 8 (03)
  • [30] Impaired cell migration and structural defects in myeloid cells overexpressing miR-30b and miR-142-3p
    Valverde, Araceli
    Nares, Salvador
    Naqvi, Afsar Raza
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2020, 1863 (11):